Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (375) Diabetes (355) Exercise and Diet Tracking for Diabetes Patients (143) Food Sciences and Nutrition Engineering (90) Gastroenterology and Hepatology (212)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/82695, first published .
Hand adding non-nutritive sweetener packet to coffee with digestive system background

Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial

Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial

Authors of this article:

Huey Shin Tan1 Author Orcid Image ;   Harvinder Kaur Gilcharan Singh1 Author Orcid Image ;   Vanitha Mariappan2 Author Orcid Image ;   Nor Aini Jamil1 Author Orcid Image ;   Suhaili Naim Mustapa3 Author Orcid Image ;   Snigdha Misra4 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Joyce P. The microbiota-drug delivery nexus: from pharmacomicrobiomics to live biotherapeutic delivery. Journal of Controlled Release 2026;400:115479 View